NCT02970422View on ClinicalTrials.gov

Chronic Obstructive Pulmonary Disease Patient Preferences Survey

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

October 31, 2017

Study Completion Date

December 12, 2018

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
OTHER

Patient Survey

Participants will answer an online survey and their medical chart information will be gathered to compare responses across disease severity.

Trial Locations (1)

H4A 3J1

Montreal Chest Institute of the McGill University Health Center (MUHC), Montreal

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

McGill University

OTHER